Russ Havranek Email
VP, Corporate Strategy and New Product Planning . PLUS THERAPEUTICS
How to contact Russ Havranek
Join and see Russ's contact info for free!Current Roles
Employees:
22Revenue:
$2.2MAbout
PLUS THERAPEUTICS (Nasdaq: PSTV) is a U.S. clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for adults and children with rare and difficult-to-treat cancers. Our lead drug candidate, Rhenium-186 Nanoliposome, is being evaluated in the NIH-supported multi-center ReSPECT clinical trials for patients with recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancer.PLUS THERAPEUTICS Address
4200 Marathon BlvdAustin, TX
United States